Psychedelic biotech startup Psylo raises $5 million Seed round
Psylo, a preclinical biotech firm, has raised $5 million in Seed funding as it looks to treat mental illness with naturally occurring psychedelic drugs. The fresh capital comes 12 months after the Sydney-based startup emerged Startmate‘s winter 21 cohort with an initial $1.1 million in capital from the likes Airtree’s Daniel Petre in a round led led… Read more »